▽British Medical Journal ●11/21 04:55 Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapyThis study found that fezolinetant was efficacious and well tolerated over a six month period for treating moderate-severe vasomotor symptoms in individuals considered unsuitable for hormone therapy.2 responsesResearch paperSafety of inpatient care i
▽Annals of Internal Medicine ●11/20 03:29 Ideas and Opinions 19 November 2024Oropouche VirusIdeas and Opinions 19 November 2024Value of Palliative Care in CancerOriginal Research 19 November 2024Denosumab and Risk for Hypercalcemia in Patients With Chronic Kidney Disease
